Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Riverside-San Bernardino-Ontario, CA MSA — September 2026
Riverside life sci pay splits: scientists up, clinical roles down.
Research Scientist pay in the Riverside metro climbed to $151,191 against a $131,354 national median, even as Clinical Research Associate pay fell to $75,000 locally while the national figure rose to $90,956.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 5.4%-5.7% — vs 4.1% national rate, August 2026
- Research Scientist advertised pay: $151,191 — vs $131,354 national median
- Clinical Research Associate advertised pay: $75,000 — vs $90,956 national median, diverging trend
- CA life sciences manufacturing employment: 143,572 workers — One-third of all CA life sciences jobs
Key takeaways
Research Scientist pay premium signals a talent-scarcity tax, not just demand.
Metro median pay of $151,191 sits nearly $20,000 above the national figure, consistent with employers paying up to compensate for the Inland Empire's thinner scientific talent pool relative to LA/Orange County. Expect this premium to persist as long as regional degree completions and biotech density lag coastal California peers.
Clinical Research Associate pay is falling locally while rising nationally.
Metro CRA pay dropped to $75,000 even as the national median advanced to $90,956, a gap exceeding 15%. Clinical operations leaders relying on local benchmarks risk under-pricing roles against a national market actively bidding CRA compensation upward.
Regulatory and data management roles are cooling faster locally than nationally.
Regulatory Affairs Specialist and Clinical Data Manager advertised pay both moved down moderately in the metro while national Regulatory pay held stable and Clinical Data Manager pay softened only in line with national trends. Consider whether local postings reflect genuine demand softening or a narrower, less competitive applicant pool skewing advertised rates downward.
Statewide manufacturing consolidation raises the stakes for build-vs-outsource calls.
BioMarin's Novato site reduction and broader California life sciences manufacturing contraction (143,572 workers, one-third of state life sciences jobs) signal that in-state manufacturing footprints are shrinking even as CMC/process development compensation nationally reaches $220K-$520K. Riverside-area manufacturing and quality leaders should factor this consolidation trend into capacity planning alongside CDMO partnership economics.
Median advertised pay by role — Riverside-San Bernardino-Ontario, CA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $115,348 | $151,191 | $162,813 | Significant increase | $131,354 |
| Clinical Research Associate | $64,906 | $75,000 | $83,000 | Moderate decline | $90,956 |
| Lab Technician | $43,770 | $47,264 | $47,840 | Significant decline | $47,402 |
| Regulatory Affairs Specialist | $90,125 | $105,398 | $114,400 | Moderate decline | $104,000 |
| Clinical Data Manager * | $108,780 | $139,084 | $152,500 | Moderate decline | $123,031 |
| Biostatistician * | $112,800 | $136,074 | $171,066 | Moderate increase | $133,322 |
| Validation Engineer * | $97,202 | $114,857 | $122,444 | Moderate decline | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Riverside-San Bernardino-Ontario MSA unemployment held near 5.4%-5.7% through mid-2026, running roughly a point above the national rate as logistics and warehousing absorb most payroll gains while information and tech roles continue to contract. Life sciences employers competing for scientific and regulatory talent in this metro draw against a labor pool shaped more by distribution-sector hiring than by biotech density, leaving specialized credential-driven roles exposed to statewide competition from LA/Orange County's stronger life sciences pipeline.
What it means
Riverside metro's Research Scientist pay climbed to a $151,191 median — above the $131,354 national figure — suggesting local employers are paying a premium to pull scientific talent into a market that lacks the life sciences density of LA or San Diego, a signal worth weighing against build-vs-relocate tradeoffs for R&D headcount. Meanwhile, Clinical Research Associate pay fell to $75,000 locally against a national median climbing toward $90,956, a divergence that raises retention risk for clinical operations teams if candidates can secure meaningfully higher offers by working remotely or relocating to coastal biotech hubs. Organizations should evaluate whether CRA compensation structures reflect true competitive exposure to statewide and national clinical talent markets rather than local benchmarks alone.
Looking ahead
Worth watching: California's EDD has not yet released September county-level data for Riverside and San Bernardino counties; watch for the mid-October release to confirm whether the metro's unemployment rate holds near 5.4%-5.7% or moves with statewide softening.
Emerging pressure point: Statewide life sciences layoffs (BioMarin, Amgen) are concentrated in Northern California, but consolidation pressure on manufacturing headcount could push displaced quality and manufacturing talent into Southern California's candidate pool, including Riverside-area facilities.
Early indicator: California's $23.9 million LA County life sciences grant aims to create 10,000 regional jobs by 2030; monitor whether any portion of this investment or related CRO/CDMO expansion extends into the Inland Empire, which could tighten regional competition for regulatory and clinical talent.
Potential inflection point: National CRA pay is up significantly while the metro figure is down moderately; a continued divergence over the next two reporting cycles would indicate Riverside employers need to recalibrate clinical operations compensation structures to stay competitive for remote-eligible candidates.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.